Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya

• Published in: JCO global oncology Vol. 7; no. 7; pp. 400 - 407
• Main Authors: Oduor, Mercy A, Lotodo, Teresa C, Vik, Terry A, Manyega, Kelvin M, Loehrer, Patrick, Omondi, Austin A, Oguda, John O, Asirwa, Fredrick C
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health 01.12.2021; American Society of Clinical Oncology
• Subjects: SPECIAL ARTICLES
• ISSN: 2687-8941; 2687-8941
• DOI: 10.1200/GO.20.00572

Despite improved treatment strategies for multiple myeloma (MM), patient outcomes in low- and middle-income countries remain poor, unlike high-income countries. Scarcity of specialized human resources and diagnostic, treatment, and survivorship infrastructure are some of the barriers that patients with MM, clinicians, and policymakers have to overcome in the former setting. To improve outcomes of patients with MM in Western Kenya, the Academic Model Providing Access to Healthcare (AMPATH) MM Program was set up in 2012. In this article, the program's activities, challenges, and future plans are described distilling important lessons that can be replicated in similar settings. Through the program, training on diagnosis and treatment of MM was offered to healthcare professionals from 35 peripheral health facilities across Western Kenya in 2018 and 2019. Access to antimyeloma drugs including novel agents was secured, and pharmacovigilance systems were developed. Finally, patients were supported to obtain health insurance in addition to receiving peer support through participation in support group meetings. This article provides an implementation blueprint for similar initiatives aimed at increasing access to care for patients with MM in underserved areas.